Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients

被引：0
|
作者：
Xiaoyi Wang
Jing Huang
Jianjun Lu
Xuemei Li
Hui Tang
Ping Shao
机构：
[1] The Second Xiangya Hospital of Central South University,Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders
[2] The Third People’s Hospital of Jiangyin City,undefined
[3] People’s Hospital of Dali Prefecture,undefined
来源：
BMC Psychiatry | / 24卷
关键词：
Risperidone; Chronic schizophrenia; Plasma concentration; polymorphism; Effect; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients
    Wang, Xiaoyi
    Huang, Jing
    Lu, Jianjun
    Li, Xuemei
    Tang, Hui
    Shao, Ping
    BMC PSYCHIATRY, 2024, 24 (01)
  • [2] A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia
    Chavan, Bir S.
    Kaur, Gurjit
    Gupta, Deepti
    Aneja, Jitender
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2018, 40 (04) : 335 - 342
  • [3] CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia
    Zeng, Lei
    Kang, ChuanYuan
    Yuan, Jing
    Zhang, Yan
    Wei, Yujun
    Xu, Li
    Zhou, Fang
    Yang, JianZhong
    SCHIZOPHRENIA RESEARCH, 2017, 188 : 50 - 51
  • [4] Pharmacogenetics of Risperidone: A Systematic Review of the Clinical Effects of CYP2D6 Polymorphisms
    Cartwright, Andrea L.
    Wilby, Kyle J.
    Corrigan, Susan
    Ensom, Mary H. H.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (03) : 350 - 360
  • [5] Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
    Jinjun Lu
    Ye Yang
    Jian Lu
    Zuqing Wang
    Yiping He
    Yeliang Yan
    Kai Fu
    Wenjuan Jiang
    Yunqing Xu
    Renrong Wu
    Wenqing Liu
    Jingping Zhao
    BMC Psychiatry, 21
  • [6] Clinical Significance of a CYP2D6 Poor Metabolizer-A Patient With Schizophrenia on Risperidone Treatment
    Bozina, Nada
    Jovanovic, Nikolina
    Lovric, Mila
    Medved, Vesna
    THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 748 - 751
  • [7] Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
    Lu, Jinjun
    Yang, Ye
    Lu, Jian
    Wang, Zuqing
    He, Yiping
    Yan, Yeliang
    Fu, Kai
    Jiang, Wenjuan
    Xu, Yunqing
    Wu, Renrong
    Liu, Wenqing
    Zhao, Jingping
    BMC PSYCHIATRY, 2021, 21 (01)
  • [8] Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia
    Yagihashi, Tatsuhiko
    Mizuno, Masafumi
    Chino, Bun
    Sato, Yuji
    Sakuma, Kei
    Takebayashi, Toru
    Takao, Takahashi
    Kosaki, Kenjiro
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (04) : 301 - 308
  • [9] Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review
    de Brabander, Emma
    Schaars, Kristian Kleine
    van Amelsvoort, Therese
    van Westrhenen, Roos
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 174 : 137 - 152
  • [10] Effects of CYP2D6 and CYP3A5 Genotypes on the Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Korean Schizophrenic Patients
    Kang, Rhee-Hun
    Jung, Sun-Min
    Kim, Kyoung-Ah
    Lee, Duk Ki
    Cho, Hyun-Kee
    Jung, Bong-Joo
    Kim, Young-Ku
    Kim, Seung-Hyun
    Han, Changsu
    Lee, Min-Soo
    Park, Ji-Young
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (03) : 272 - 277
12345